Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use of inhalable powder formulation comprising growth hormone for preventing or treating NMDA receptor hypofunction-related diseases

US Patent 9795653 · Granted Oct 24, 2017

Assignee

Inventors

View full patent text on Google Patents →